150 related articles for article (PubMed ID: 24371299)
1. Arrestin(g) podocyte injury with endothelin antagonism.
Tan RJ; Liu Y
J Am Soc Nephrol; 2014 Mar; 25(3):423-5. PubMed ID: 24371299
[No Abstract] [Full Text] [Related]
2. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
[TBL] [Abstract][Full Text] [Related]
3. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
[TBL] [Abstract][Full Text] [Related]
4. Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.
Harvey TW; Engel JE; Chade AR
Am J Nephrol; 2016; 43(2):74-84. PubMed ID: 26930122
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
[TBL] [Abstract][Full Text] [Related]
6. Convergent pathways link the endothelin A receptor to the beta-catenin: the beta-arrestin connection.
Rosanò L; Bagnato A
Cell Cycle; 2009 May; 8(10):1462-3. PubMed ID: 19395853
[No Abstract] [Full Text] [Related]
7. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
[TBL] [Abstract][Full Text] [Related]
8. Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats.
Du QH; Han L; Jiang JJ; Li PT; Wang XY; Jia X
World J Gastroenterol; 2013 Apr; 19(13):2065-72. PubMed ID: 23599626
[TBL] [Abstract][Full Text] [Related]
9. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.
Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075
[TBL] [Abstract][Full Text] [Related]
10. Regulation and intracellular trafficking pathways of the endothelin receptors.
Bremnes T; Paasche JD; Mehlum A; Sandberg C; Bremnes B; Attramadal H
J Biol Chem; 2000 Jun; 275(23):17596-604. PubMed ID: 10747877
[TBL] [Abstract][Full Text] [Related]
11. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
Liu J; Li QX; Wang XJ; Zhang C; Duan YQ; Wang ZY; Zhang Y; Yu X; Li NJ; Sun JP; Yi F
Cell Death Dis; 2016 Apr; 7(4):e2183. PubMed ID: 27054338
[TBL] [Abstract][Full Text] [Related]
12. beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport.
Imamura T; Huang J; Dalle S; Ugi S; Usui I; Luttrell LM; Miller WE; Lefkowitz RJ; Olefsky JM
J Biol Chem; 2001 Nov; 276(47):43663-7. PubMed ID: 11546805
[TBL] [Abstract][Full Text] [Related]
13. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
14. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
Rosanò L; Bagnato A
J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans.
Barton M
Biochim Biophys Acta; 2010 Dec; 1802(12):1203-13. PubMed ID: 20359530
[TBL] [Abstract][Full Text] [Related]
16. Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.
Dufek B; Meehan DT; Delimont D; Cheung L; Gratton MA; Phillips G; Song W; Liu S; Cosgrove D
Kidney Int; 2016 Aug; 90(2):300-310. PubMed ID: 27165837
[TBL] [Abstract][Full Text] [Related]
17. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
[TBL] [Abstract][Full Text] [Related]
18. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.
Roosterman D; Cottrell GS; Padilla BE; Muller L; Eckman CB; Bunnett NW; Steinhoff M
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11838-43. PubMed ID: 17592116
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
Jones BW; Hinkle PM
J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
